Evolution Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-43
Closed -$16K 301
2021
Q3
$16K Sell
43
-55
-56% -$20.9K ﹤0.01% 343
2021
Q2
$37K Sell
98
-6
-6% -$2.29K 0.01% 234
2021
Q1
$37K Hold
104
0.01% 225
2020
Q4
$33K Sell
104
-11
-10% -$3.38K 0.01% 213
2020
Q3
$31K Hold
115
0.01% 226
2020
Q2
$30K Buy
115
+1
+0.9% +$267 0.01% 173
2020
Q1
$26K Sell
114
-47
-29% -$12.8K 0.01% 138
2019
Q4
$49K Buy
161
+146
+973% +$40.2K 0.01% 149
2019
Q3
$4K Sell
15
-180
-92% -$49.3K ﹤0.01% 309
2019
Q2
$55K Buy
+195
New +$53.3K 0.02% 79

Other funds holding ELV

Evolution Wealth Advisors's ELV Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 43 shares — an estimated $16K sold.

Evolution Wealth Advisors first reported a position in ELV in Q2 2019 and held it in 10 quarters. The position peaked at $55K in Q2 2019. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 43 Elevance Health shares in Q4 2021, an estimated $16K.
  • Evolution Wealth Advisors first reported a position in Elevance Health in Q2 2019 and held it in 10 quarters.
  • Evolution Wealth Advisors's Elevance Health position peaked at $55K in Q2 2019.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.